Literature DB >> 1905325

Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein.

C Pothoulakis1, J T LaMont, R Eglow, N Gao, J B Rubins, T C Theoharides, B F Dickey.   

Abstract

The purpose of this study was to characterize the surface receptor for toxin A, the enterotoxin from Clostridium difficile, on rabbit intestinal brush borders (BB) and on rat basophilic leukemia (RBL) cells. Purified toxin A was radiolabeled using a modified Bolton-Hunter method to sp act 2 microCi/micrograms, with retention of full biologic activity. 3H-Toxin A bound specifically to a single class of receptors on rabbit BB and on RBL cells with dissociation constants of 5.4 x 10(-8) and 3.5 x 10(-8) M, respectively. RBL cells were highly sensitive to toxin A (cell rounding) and had 180,000 specific binding sites per cell, whereas IMR-90 fibroblasts were far less sensitive to toxin A and lacked detectable specific binding sites. Exposure of BB to trypsin or chymotrypsin significantly reduced 3H-toxin A specific binding. Preincubation of BB with Bandeirea simplicifolia (BS-1) lectin also reduced specific binding, and CHAPS-solubilized receptors could be immobilized with WGA-agarose. The addition of 100 nM toxin A accelerated the association of 35S-GTP gamma S with rabbit ileal BB, and preincubation of BB with the GTP analogues GTP gamma S or Gpp(NH)p, significantly reduced 3H-toxin A specific binding. Our data indicate that the membrane receptor for toxin A is a galactose and N-acetyl-glucosamine-containing glycoprotein which appears to be coupled to a G protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905325      PMCID: PMC296011          DOI: 10.1172/JCI115267

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  METHOD FOR ASSAY OF INTESTINAL DISACCHARIDASES.

Authors:  A DAHLQVIST
Journal:  Anal Biochem       Date:  1964-01       Impact factor: 3.365

2.  Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein.

Authors:  L S Gray; K S Huber; M C Gray; E L Hewlett; V H Engelhard
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

Review 3.  G proteins: transducers of receptor-generated signals.

Authors:  A G Gilman
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

4.  Lymphocyte activation by HIV-1 envelope glycoprotein.

Authors:  H Kornfeld; W W Cruikshank; S W Pyle; J S Berman; D M Center
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

5.  Pertussis toxin triggers rapid second messenger production in human T lymphocytes.

Authors:  P M Rosoff; R Walker; L Winberry
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

6.  Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain.

Authors:  P Goldsmith; P Gierschik; G Milligan; C G Unson; R Vinitsky; H L Malech; A M Spiegel
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

7.  Response of mouse intestinal loop to botulinum C2 toxin: enterotoxic activity induced by cooperation of nonlinked protein components.

Authors:  I Ohishi
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

8.  Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine.

Authors:  M Mobassaleh; A Donohue-Rolfe; M Jacewicz; R J Grand; G T Keusch
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

9.  Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.

Authors:  G Hecht; C Pothoulakis; J T LaMont; J L Madara
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

10.  Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes.

Authors:  C Pothoulakis; R Sullivan; D A Melnick; G Triadafilopoulos; A S Gadenne; T Meshulam; J T LaMont
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

View more
  23 in total

1.  Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A.

Authors:  C Pothoulakis; R J Gilbert; C Cladaras; I Castagliuolo; G Semenza; Y Hitti; J S Montcrief; J Linevsky; C P Kelly; S Nikulasson; H P Desai; T D Wilkins; J T LaMont
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 2.  Refractory Clostridium difficile-associated diarrhea.

Authors:  Shilpa Grover; Matthew J Hamilton; David L Carr-Locke
Journal:  MedGenMed       Date:  2007-05-29

3.  Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.

Authors:  I Castagliuolo; M F Riegler; L Valenick; J T LaMont; C Pothoulakis
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 4.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

Review 5.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

6.  Intravenous immunoglobulin therapy for severe Clostridium difficile colitis.

Authors:  J Salcedo; S Keates; C Pothoulakis; M Warny; I Castagliuolo; J T LaMont; C P Kelly
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

7.  Development and optimization of a novel assay to measure neutralizing antibodies against Clostridium difficile toxins.

Authors:  Jinfu Xie; Julie Zorman; Lani Indrawati; Melanie Horton; Keri Soring; Joseph M Antonello; Yuhua Zhang; Susan Secore; Matthew Miezeiewski; Su Wang; Anthony D Kanavage; Julie M Skinner; Irene Rogers; Jean-Luc Bodmer; Jon H Heinrichs
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

8.  Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine.

Authors:  I Kurose; C Pothoulakis; J T LaMont; D C Anderson; J C Paulson; M Miyasaka; R Wolf; D N Granger
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins.

Authors:  C P Kelly; C Pothoulakis; F Vavva; I Castagliuolo; E F Bostwick; J C O'Keane; S Keates; J T LaMont
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 10.  New developments in acute diarrhea.

Authors:  D I Mehta; E Lebenthal
Journal:  Curr Probl Pediatr       Date:  1994-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.